Back

Uremic toxin induced endothelial dysfunction can be restored by inhibition of the aryl hydrocarbon receptor: implications for cardiovascular disease treatment in chronic kidney disease patients

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Pharmacology, angiogenesis and cardiovascular disease Drugs, Drug Targets ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Andrew Kompa

St Vincent's Hospital, Melbourne (Australia)

11 More presentations in this session

Presentation thumbnail
Mechanistic insight on the cardioprotective effect of levosimendan against doxorubicin induced cardiomyopathy: Pivotal role of PKA signaling.
Professor I. Andreadou (Athens, GR)
Abstract
Presentation thumbnail
Endothelial adenosine-to-inosine RNA editing is indispensable for vascular integrity
Doctor S. Tual-Chalot (Newcastle-Upon-Tyne, GB)
Abstract
Presentation thumbnail
Intravenous administration of atorvastatin early after cardiac ischemia attenuates adverse left ventricular remodeling, ameliorates cardiac function and limits the deleterious effects of reinfarction
Doctor G. Vilahur (Barcelona, ES)
Abstract
Presentation thumbnail
Impact of 719 trp>arg polymorphism of kif 6 gene on contrast induced nephropathy and modulation of statin therapy effectiveness
Professor G. De Luca (Messina, IT)
Presentation thumbnail
Carvedilol and its analogue VK-II-86 attenuate stretch-induced manifestations of mechanoelectric feedback.
Miss I. Del Canto Serrano (Valencia, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Pharmacology, angiogenesis and cardiovascular disease

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources